Orencia Outperforming Rituxan In RA, Bristol Says; Branded DTC To Start Soon
Executive Summary
Physicians more frequently prescribe Bristol-Myers Squibb's Orencia than Genentech/Biogen Idec's Rituxan for rheumatoid arthritis, Bristol Worldwide Pharmaceuticals President Lamberto Andreotti said